You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TOPIC #366- PHASE II SBIR CONTRACT- CLONOGENIC HIGH- THROUGHPUT ASSAY FOR SCREENING RADIATION MODULATION
SBC: SUVICA INC Topic: NCIClonogenic assays measure the ability of single cells to proliferate and form a colonyThis process approximates closely the regrowth and recurrence of tumors after treatment with radiation or chemotherapyproviding an assay to screen for drugs that block this processYetclonogenic assays are labor intensive and too cumbersome for high throughout screeningHTSof compound librariesHere we propose to de ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
TOPIC 389- INTELLIGENT SOFTWARE FOR RADIATION THERAPY PLANNING
SBC: RADIASOFT LLC Topic: NCIBesides surgeryradiotherapy is the most effective treatment modality for localized prostate cancerThe success of radiotherapy stems from the exploit of a therapeutic window in tumor response and normal tissue tolerance which maximizes the chance of sterilizing the tumor while sparing the surrounding normal tissue from severe damageThis requires an accurate and individualized radiation dose distrib ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Bioinformatic Tools for Interpretation of Glycan Array Data
SBC: Z BIOTECH, LLC Topic: 400Project SummaryAbstract There is an urgent need of bioinformatic tools for mining glycan array data in order to accurately and statistically study the interactions between cell surface glycans and glycan binding proteinsWe propose here to develop a software and hardware integrated system for the interpretation of glycan array dataThe problem with existing glycan array data mining tools is that the ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Personal Mercury Monitor for Exposure Measurements
SBC: LUDLUM MEASUREMENTS INC Topic: 113Personal Mercury Monitor for Exposure Measurements Project Summary/AbstractWorkers in the oil and natural gas industry are vulnerable to exposure to toxic mercury (Hg) vapor as a result of routine inspection and maintenance of equipment such as compressors and other process equipment that concentrate species of low volatility over time. Exposure of workers to elemental mercury vapor is of concern ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Extended release formulation of a new IOP lowering drug for improved treatment of glaucoma
SBC: OCULO THERAPY LLC Topic: NEIGlaucoma is the leading cause of irreversible blindness in the world. Elevated intraocular pressure (IOP) is the most significant risk factor contributing to death of retinal neurons and resulting visual field loss in primary open angle glaucoma, the most common form of glaucoma. The current standard of care for glaucoma includes IOP- lowering medications delivered topically as eye drops, which de ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Point-of-Care Prognostic Tool for Sepsis
SBC: MBIO DIAGNOSTICS INC Topic: 300Sepsis is a devastating cause of morbidity and mortality in intensive care units (ICUs), with estimates of U.S. incidence ranging from 894,000 to 3.1 million cases annually. The heterogeneity of clinical presentation (etiology, patient history, severity, etc.) creates a major challenge for patient management and has significantly complicated development of new therapies, almost all of which have f ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes
SBC: Op-T-Mune, Inc Topic: NIAIDType 1 Diabetes (T1D) affects an ever growing population. While this disease typically has been associated with juveniles, the disease in adult populations is rapidly increasing. The defining clinical component is insulin loss, which occurs because of sustained inflammation in the islets. At present there is no means to prevent or reverse insulin loss. A major inflammatory pathway in T1D that cont ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Human Milk Concentration Device; Point of Care Technology for Feeding Preterm Infants in Intensive Care
SBC: MOTHER'S MILK IS BEST, INC. Topic: NICHDHuman milk is the best feeding option for preterm infantsHoweverdue to the high nutrient needs of preterm infants in US Neonatal Intensive Care UnitsNICUsthe mother s own milk is most often mixed with bovine milk sourced fortifiers to achieve goal nutrient levelsThe Human Milk ConcentrationHMCdevice concentrates a mother s milk by removing water so that preterm infants can receive adequate nutrien ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Identifying the precursor to oxytocin-induced uterine tachysystole by monitoring with uterine EMG
SBC: PreTel, Inc. Topic: NICHDApproximatelyof all women in the USoverannuallyare exposed to IV oxytocin at some point during labor to increase the frequency and strength of uterine contractionsOxytocin is classified as a high alert medication requiring clinical vigilanceOxytocin is generally safebut adverse outcomes arise when contractions become too frequenta condition called tachysystoleTachysystole is associated with fetal ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Direct-read monitor for airborne viral pathogens
SBC: AEROSOL DEVICES INC Topic: NIAIDAerosolized pathogenssuch as Influenza virusescan spread rapidly and silently throughout a populationcausing severe outbreaks that can be difficult to controlEarly detection of these airborne pathogens is key to controlling outbreaksespecially among vulnerable populations such as in hospitalstreatment centers or nursing homesYet available methods are neither rapidnor portableCurrent methods rely h ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health